Literature DB >> 16681187

Vaccine innovation: lessons from World War II.

Kendall Hoyt1.   

Abstract

World War II marked a watershed in the history of vaccine development as the military, in collaboration with academia and industry, achieved unprecedented levels of innovation in response to war-enhanced disease threats such as influenza and pneumococcal pneumonia. In the 1940s alone, wartime programs contributed to the development of new or significantly improved vaccines for 10 of the 28 vaccine-preventable diseases identified in the 20th century. This article examines the historical significance of military organizations and national security concerns for vaccine development in the United States.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681187     DOI: 10.1057/palgrave.jphp.3200064

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  5 in total

Review 1.  The influenza pandemic of 2009: lessons and implications.

Authors:  Paul Shapshak; Francesco Chiappelli; Charurut Somboonwit; John Sinnott
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 2.  Pandemism of swine flu and its prospective drug therapy.

Authors:  R K Saxena; P Tripathi; G Rawat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-16       Impact factor: 3.267

Review 3.  Civil-military cooperation in the management of infectious disease outbreaks: a scoping review.

Authors:  Jacobine Janse; Jori Pascal Kalkman; George Louis Burchell; Adriaan Pieter Cornelis Christiaan Hopperus Buma; Teun Zuiderent-Jerak; Myriame Thérèse Isabella Beatrice Bollen; Aura Timen
Journal:  BMJ Glob Health       Date:  2022-06

Review 4.  Clinical vaccine development.

Authors:  Seunghoon Han
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

5.  A newly found handbook for developing vaccines during World War II in China: the legacy of global responses to crises.

Authors:  Bin Ni; Bingqing Xu; Yicheng Ni
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.